J. Duclos‐Vallée

发表

Portopulmonary hypertension in the current era of pulmonary hypertension management.

M. Humbert, M. Fertin, N. Lamblin, 2020, Journal of hepatology.

Long term results of liver transplantation for alpha-1 antitrypsin deficiency.

D. Samuel, J. Dumortier, O. Guillaud, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

ATP release after partial hepatectomy regulates liver regeneration in the rat.

D. Samuel, T. Tordjmann, L. Combettes, 2010, Journal of hepatology.

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference.

V. de Lédinghen, D. Samuel, J. Dumortier, 2019, Journal of hepatology.

[Current trend: autoimmune hepatitis].

C. Johanet, É. Ballot, J. Duclos‐Vallée, 2005, Gastroenterologie clinique et biologique.

G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)

S. Chevret, S. Pol, V. Bourcier, 2015 .

Advanced epithelioid hemangioendothelioma of the liver: could lenvatinib offer a bridge treatment to liver transplantation?

D. Samuel, A. Coilly, C. Guettier, 2022, Therapeutic advances in medical oncology.

Safety of sofosbuvir‐based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study

V. de Lédinghen, D. Samuel, J. Dumortier, 2018, Alimentary pharmacology & therapeutics.

Consensus conference: Indications for Liver Transplantation, January 19 and 20, 2005, Lyon‐Palais Des Congrès

Leroy, C. Jacquelinet, T. Asselah, 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Orthotopic liver transplantation for alcoholic cirrhosis: a long time follow up

D. Samuel, H. Bismuth, C. Féray, 2001 .

Infections in solid organ transplant HIV-infected patients.

J. Miro, N. Mueller, P. Grossi, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update.

J. Miro, N. Terrault, P. Stock, 2015, Journal of hepatology.

Optimal Management of HCV Transplant Patients

D. Samuel, B. Roche, A. Coilly, 2014, Current Hepatology Reports.

Sofosbuvir‐based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation

V. de Lédinghen, D. Samuel, J. Dumortier, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Optimum timing of treatment for hepatitis C infection relative to liver transplantation.

D. Samuel, B. Roche, A. Coilly, 2016, The lancet. Gastroenterology & hepatology.

[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience].

D. Samuel, H. Bismuth, C. Féray, 2001, Gastroentérologie Clinique et Biologique.

Liver transplantation in the human immunodeficiency virus–hepatitis C virus coinfected patient: Time to sum up

D. Samuel, J. Duclos‐Vallée, 2013, Hepatology.

Liver transplantation for alcoholic hepatitis. Current situation and future

D. Samuel, J. Duclos‐Vallée, M. Gelu-Simeon, 2014, Hepatology International.

[Radiation-induced stricture of the papilla and the common bile duct: successful treatment with balloon dilation].

F. Prat, M. Ducreux, J. Duclos‐Vallée, 2001, Gastroenterologie clinique et biologique.

Enfuvirtide: A safe and effective antiretroviral agent for human immunodeficiency virus–infected patients shortly after liver transplantation

D. Samuel, L. Bonhomme-Faivre, D. Vittecoq, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft

D. Samuel, G. Peytavin, L. Bonhomme-Faivre, 2013, AIDS.

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, Journal of Cannabis Research.

Conformational epitopes on CYP2D6 are recognized by liver/kidney microsomal antibodies.

J. Duclos‐Vallée, O. Hajoui, A. Yamamoto, 1995, Gastroenterology.

TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload

R. Boisgard, T. Tordjmann, E. Vibert, 2020, JHEP reports : innovation in hepatology.

[Treatment of hepatitis C virus associated extrahepatic manifestations].

J. Duclos‐Vallée, 2002, Gastroenterologie clinique et biologique.

Latent autoimmune thyroid disease in patients with chronic HCV hepatitis.

D. Hartmann, D. Pateron, M. Beaugrand, 1993, Journal of hepatology.

Latent autoimmune thyroid disease in patients with chronic HCV hepatitis.

D. Hartmann, D. Pateron, M. Beaugrand, 1992, Journal of hepatology.

[Wilson disease].

F. Woimant, P. Chappuis, J. Trocello, 2009, Presse medicale.

Long‐term outcome in liver transplantation candidates with portopulmonary hypertension

M. Humbert, D. Samuel, F. Durand, 2017, Hepatology.

Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients.

D. Samuel, E. Ballot, F. Saliba, 2012, Journal of hepatology.

Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients

D. Samuel, H. François, A. Durrbach, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Liver transplantation as a rescue therapy for severe neurologic forms of Wilson disease.

V. de Lédinghen, W. Meissner, E. Broussolle, 2020, Neurology.

Outcome of Portopulmonary Hypertension After Liver Transplantation: Perhaps Not So Optimistic.

L. Savale, O. Sitbon, J. Duclos‐Vallée, 2018, Transplantation.

Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis.

J. Bach, J. Duclos‐Vallée, C. Johanet, 2000, Journal of hepatology.

Liver transplantation: The effect of new HCV drugs on liver transplantation outcomes

D. Samuel, J. Duclos‐Vallée, 2015, Nature Reviews Gastroenterology &Hepatology.

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

E. Vicaut, M. Dougados, M. Humbert, 2021, The Lancet Respiratory Medicine.

Direct-Acting Antiviral Medications for Hepatitis C Virus Infection and Pulmonary Arterial Hypertension.

M. Humbert, D. Samuel, X. Jaïs, 2016, Chest.

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF RARE GENETIC LIVER DISEASES.

V. de Lédinghen, O. Guillaud, N. Ganne-Carrié, 2021, Clinics and research in hepatology and gastroenterology.

SPRi-Based Strategy to Identify Specific Biomarkers in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Autoimmune Hepatitis

D. Samuel, E. Ballot, M. Buckle, 2013, PloS one.

Evidence of Adult Features and Functions of Hepatocytes Differentiated from Human Induced Pluripotent Stem Cells and Self-Organized as Organoids

A. Messina, A. Dubart-Kupperschmitt, L. Humbert, 2022, Cells.

Complete remission of unresectable hepatocellular carcinoma on healthy liver by the combination of aggressive surgery and high-dose-intensity chemotherapy by CPT-11.

F. Goldwasser, D. Azoulay, J. Duclos‐Vallée, 2000, Anti-cancer drugs.

Identification by Proteomic Tool of Atypical Anti‐Liver/Kidney Microsome Autoantibodies Targets in de Novo Autoimmune Hepatitis after Liver Transplantation

D. Samuel, E. Ballot, J. Vinh, 2007, Annals of the New York Academy of Sciences.

News and challenges in the treatment of hepatitis C in liver transplantation

D. Samuel, B. Roche, A. Coilly, 2016, Liver international (Print).

Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)

J. Zucman‐Rossi, F. Carrat, F. Zoulim, 2022, Journal of clinical medicine.

Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?

V. de Lédinghen, D. Samuel, J. Dumortier, 2015, PloS one.

Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis

D. Samuel, F. Saliba, C. Guettier, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Acute hepatitis with periportal confluent necrosis associated with human herpesvirus 6 infection in liver transplant patients.

D. Samuel, C. Guettier, A. Roque-Afonso, 2013, American journal of clinical pathology.

Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis.

D. Samuel, G. Alonso, T. Tordjmann, 2011, Journal of hepatology.

A new indication for liver transplantation: Nodular regenerative hyperplasia in human immunodeficiency virus–infected patients

D. Samuel, S. Pol, V. Mallet, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation

M. Sebagh, J. Duclos‐Vallée, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis.

A. Louvet, J. Duclos‐Vallée, D. Debray, 2022, Clinics and research in hepatology and gastroenterology.

Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis

D. Samuel, F. Saliba, B. Roche, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Histologic Findings Predictive of a Diagnosis of De novo Autoimmune Hepatitis After Liver Transplantation in Adults

D. Samuel, F. Saliba, A. Coilly, 2013, Transplantation.

Significance of isolated hepatic veno‐occlusive disease/sinusoidal obstruction syndrome after liver transplantation

D. Samuel, F. Saliba, L. Bonhomme-Faivre, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation.

J. Dumortier, F. Durand, N. Kamar, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Reply to "Acute severe autoimmune hepatitis - timing for steroids and role of other immunosuppressive agents".

J. Duclos‐Vallée, E. De Martin, 2021, Journal of hepatology.

Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen

D. Samuel, C. Féray, B. Roche, 2001, Journal of medical virology.

Resection or Transplantation for Early Hepatocellular Carcinoma in a Cirrhotic Liver: Does Size Define the Best Oncological Strategy?

D. Samuel, E. Vibert, C. Guettier, 2012, Annals of surgery.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study.

V. de Lédinghen, D. Samuel, J. Dumortier, 2016, Journal of hepatology.

Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients

D. Samuel, P. Gual, J. Bertrand-Michel, 2017, Scientific Reports.

Bone status and fractures in 85 adults with Wilson’s disease

F. Woimant, J. Trocello, F. Lioté, 2014, Osteoporosis International.

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.

D. Samuel, J. Dumortier, O. Guillaud, 2014, Journal of hepatology.

Heterogeneous nuclear ribonucleoprotein A2/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis

D. Samuel, E. Ballot, V. Labas, 2004, Proteomics.

Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool

D. Samuel, E. Ballot, F. Le Naour, 2008, Hepatology.

Liver transplantation for fulminant hepatitis related to nevirapine therapy

D. Samuel, E. Vibert, T. Antonini, 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen–positive liver grafts receiving hepatitis B immunoglobulins

D. Samuel, B. Roche, A. Roque-Afonso, 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence

D. Samuel, H. Bismuth, E. Ballot, 2003, Gut.

Could post‐liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?

D. Samuel, H. Bismuth, E. Ballot, 2005, Clinical transplantation.

Are HIV-infected patients candidates for liver transplantation?

R. Weber, D. Samuel, N. Terrault, 2008, Journal of hepatology.

Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort)

T. Asselah, F. Carrat, S. Pol, 2022, Antioxidants.

Management of post transplant hepatitis C in the direct antiviral agents era

D. Samuel, B. Roche, A. Coilly, 2015, Hepatology International.

Hepatitis C and Liver Transplantation in the HIV Co-infected Patients

D. Samuel, T. Antonini, J. Duclos‐Vallée, 2014 .

G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort

J. Dumortier, R. Anty, C. Duvoux, 2015 .

Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity

D. Samuel, B. Roche, F. Medja, 2009, AIDS.

Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

D. Samuel, H. Bismuth, C. Féray, 2007, Hepatology.

Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient

D. Samuel, H. Bismuth, C. Féray, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Fibrosing Cholestatic Hepatitis in HIV/HCV Co‐Infected Transplant Patients—Usefulness of Early Markers After Liver Transplantation

D. Samuel, B. Roche, A. Coilly, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation.

D. Samuel, J. Dumortier, C. Cagnot, 2022, Clinics and research in hepatology and gastroenterology.

Intense isolated expression with preS1 (large protein) antibodies in the liver graft associated with severe acute hepatitis B virus reactivation.

D. Samuel, J. Emile, C. Féray, 2001, Journal of hepatology.

Do the epidemiology, physiological mechanisms and characteristics of hepatocellular carcinoma in HIV-infected patients justify specific screening policies?

D. Samuel, J. Trinchet, L. Meyer, 2014, AIDS.

Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 Study

D. Samuel, L. Bonhomme-Faivre, D. Vittecoq, 2007, Clinical pharmacokinetics.

Molecular Mechanisms of Hepatotoxicity.

J. Duclos‐Vallée, Antonietta Messina, 2023, International Journal of Molecular Sciences.

Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma

Eric Ballot, Didier Samuel, Catherine Guettier, 2016, Journal of Translational Medicine.

Persistence of Yellow Fever Vaccine–Induced Antibodies After Solid Organ Transplantation

D. Samuel, M. Mamzer-Bruneel, H. François, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Transplantation hépatique de l'adulte à partir de donneur vivant

D. Samuel, H. Bismuth, C. Féray, 2008 .

Early liver transplantation for severe alcoholic hepatitis.

F. Pruvot, D. Samuel, A. Duhamel, 2011, The New England journal of medicine.

12 Weeks of a Ribavirin‐Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation

J. Dumortier, C. Cagnot, A. Tran, 2018, Hepatology.

Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.

D. Samuel, J. Dumortier, F. Durand, 2016, World journal of gastroenterology.

Post–Liver Transplantation Sinusoidal Obstruction Syndrome With Refractory Ascites Induced by Mycophenolate Mofetil

D. Samuel, H. Bismuth, C. Féray, 2020, Hepatology.

Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study.

T. Asselah, D. Thabut, F. Carrat, 2021, Clinics and research in hepatology and gastroenterology.

Comparative analysis of outcomes after liver resection and liver transplantation for early stages hepatocellular carcinoma in HIV-infected patients. An intention-to-treat analysis.

D. Samuel, E. Vibert, R. Adam, 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids.

E. Ballot, J. Emile, C. Guettier, 2005, Gastroenterologie clinique et biologique.

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

E. Vicaut, M. Dougados, M. Humbert, 2021, The Lancet Rheumatology.

The impact of treatment of hepatitis C with DAAs on the occurrence of HCC

D. Samuel, B. Roche, A. Coilly, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Reply to: "Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation".

A. Coilly, M. Sebagh, J. Duclos‐Vallée, 2014, Journal of hepatology.

Practical Management of Boceprevir and Immunosuppressive Therapy in Liver Transplant Recipients with Hepatitis C Virus Recurrence

D. Samuel, B. Roche, A. Coilly, 2012, Antimicrobial Agents and Chemotherapy.

DHEA and progesterone have a protective effect on ribavirin-induced hemolysis

A. Coilly, M. Sebagh, J. Duclos‐Vallée, 2014 .

Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients After Liver Transplantation: Results From the ANRS CO23 CUPILT Study

V. de Lédinghen, D. Samuel, J. Dumortier, 2018, Transplantation.

Direct‐acting antiviral agent–based regimen for HCV recurrence after combined liver‐kidney transplantation: Results from the ANRS CO23 CUPILT study

V. de Lédinghen, D. Samuel, J. Dumortier, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).

A. Samri, B. Autran, D. Samuel, 2009, Journal of hepatology.

T Cells Subtypes in a Patient With Interferon-&agr; Induced Sarcoidosis

G. Carcelain, B. Autran, J. Monsuez, 2009, The American journal of the medical sciences.

Reply:

D. Samuel, E. Vibert, R. Adam, 2011 .

Risk Factors for Infection in Chronic Hepatitis C : A High Prevalence of Sexual Exposure Among Human Immunodeficiency Virus – Coinfected Women To the

D. Samuel, P. Ichai, J. Duclos‐Vallée, 2011 .

Liver transplantation for hepatocellular carcinoma: The impact of human immunodeficiency virus infection

D. Samuel, M. Ghigna, E. Vibert, 2011, Hepatology.

Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort

V. de Lédinghen, D. Samuel, F. Durand, 2019, European Journal of Clinical Pharmacology.

Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation

D. Samuel, A. Coilly, D. Vittecoq, 2015, AIDS.

Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals

D. Samuel, B. Roche, A. Coilly, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.

J. Molina, D. Vittecoq, S. Haim-Boukobza, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Opportunistic infections after liver transplantation in patients infected with human immunodeficiency virus

J. Duclos‐Vallée, E. Teicher, 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Long term results of liver transplantation for Wilson's disease: experience in France.

D. Samuel, K. Boudjema, J. Dumortier, 2014, Journal of hepatology.

The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable.

D. Samuel, A. Coilly, P. Ichai, 2015, Journal of hepatology.

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome

C. Degott, N. Ganne-Carrié, A. Hadengue, 1995, Digestive Diseases and Sciences.

Early liver transplantation for corticosteroid non-responders in acute severe autoimmune hepatitis: the SURFASA score.

V. de Lédinghen, P. Potier, D. Samuel, 2021, Journal of hepatology.

Autoimmune acute liver failure

D. Samuel, P. Ichai, J. Duclos‐Vallée, 2011, Hepatology.

Phosphorylation of the hepatitis B virus core protein by glyceraldehyde-3-phosphate dehydrogenase protein kinase activity.

H. Mabit, M. Petit, J. Duclos‐Vallée, 1998, The Journal of general virology.

Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis.

M. Ziol, V. de Lédinghen, J. Zucman‐Rossi, 2022, Journal of hepatology.

Advanced Techniques and Awaited Clinical Applications for Human Pluripotent Stem Cell Differentiation into Hepatocytes

A. Messina, J. Duclos‐Vallée, E. Luce, 2021, Hepatology.

A versatile microfluidic tool for the 3D culture of HepaRG cells seeded at various stages of differentiation

B. Le Pioufle, A. Messina, I. B. Mosbah, 2021, Scientific Reports.

Very prolonged liposomal amphotericin B use leading to a lysosomal storage disease.

O. Lambotte, O. Lortholary, S. Blanche, 2014, International journal of antimicrobial agents.

Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma

Philippe Broët, Cyril Dalmasso, Catherine Guettier, 2015, BMC Cancer.

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis

F. Zoulim, D. Samuel, M. Levrero, 2023, JHEP reports : innovation in hepatology.

Fatal reactivation of hepatitis B virus mutant following cytotoxic treatment.

M. Loriot, P. Marcellin, P. Laurent-Puig, 1994, Journal of hepatology.

Liver transplantation for fulminant hepatic failure due to cocaine intoxication in an alcoholic hepatitis C virus-infected patient.

D. Samuel, J. Emile, M. Bemelmans, 2002, Transplantation.

Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort.

S. Chevret, S. Pol, V. Bourcier, 2022, Journal of hepatology.

[Liver transplantation for intrahepatic Rendu-Osler-Weber's disease: the Paul Brousse hospital experience].

D. Samuel, H. Bismuth, J. Emile, 2002, Gastroenterologie clinique et biologique.

Hepatic Arteriovenous Malformation: The Search for a PTEN Mutation!

D. Samuel, M. Eyries, C. Féray, 2021, Hepatology.

Management of HCV transplant patients with triple therapy

D. Samuel, B. Roche, A. Coilly, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Microencapsulated Hepatocytes Differentiated from Human Induced Pluripotent Stem Cells: Optimizing 3D Culture for Tissue Engineering Applications

A. Messina, C. Legallais, J. Duclos‐Vallée, 2023, Cells.

Immunoproteomic Analysis of Potentially Severe Non‐Graft‐Versus‐Host Disease Hepatitis After Allogenic Bone Marrow Transplantation

J. L. Le Caer, D. Samuel, E. Ballot, 2013, Hepatology.

Liver transplantation for autoimmune hepatitis: Pre‐transplant does not predict the early post‐transplant outcome

D. Samuel, J. Dumortier, O. Guillaud, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Acute pancreatitis revealing diffuse infiltration of the pancreas by melanoma.

F. Prat, P. Bedossa, V. Boige, 1997, Pancreas.

The difficulty in timing for liver transplantation in cirrhotic patients coinfected with HIV: In search for a prognosis score

D. Samuel, J. Duclos‐Vallée, 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Bile Acid pool composition and Gallbladder function are controlled by TGR5 to protect the liver against Bile Acid overload

R. Boisgard, T. Tordjmann, E. Vibert, 2020, bioRxiv.

Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.

D. Samuel, H. Bismuth, C. Féray, 2005, Journal of hepatology.

Molecular pathology of Wilson's disease: a brief.

D. Cassio, J. Duclos‐Vallée, V. Lalioti, 2010, Journal of hepatology.

Long‐term outcome of liver transplantation for autoimmune hepatitis: A French nationwide study over 30 years

D. Maucort-Boulch, D. Samuel, J. Dumortier, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Model for end‐stage liver disease exceptions in the context of the french model for end‐stage liver disease score–based liver allocation system

D. Thabut, R. Moreau, D. Samuel, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Is Frederic Chopin's Death Elucidated?

S. Erlinger, J. Duclos‐Vallée, 2018, The American journal of medicine.

Impact of a first study of early transplantation in acute alcoholic hepatitis: Results of a nationwide survey in french liver transplantation programs

J. Dumortier, O. Guillaud, C. Duvoux, 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Long-term results of the first study of early liver transplantation for alcoholic hepatitis

D. Samuel, J. Dumortier, F. Durand, 2020, Journal of Hepatology.

Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT).

D. Samuel, F. Durand, M. Carrieri, 2017, Clinics and research in hepatology and gastroenterology.

Hepatitis E infection in patients with severe acute alcoholic hepatitis

D. Samuel, F. Saliba, B. Roche, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.

M. Nishioka, J. Bach, K. Arima, 1998, Journal of hepatology.

A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type‐2 (AIH‐2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay

J. Bach, J. Duclos‐Vallée, C. Johanet, 1997, Clinical and experimental immunology.

Low cross-neutralization of hepatitis C correlates with liver disease in immunocompromized patients

D. Lavillette, F. Cosset, D. Samuel, 2015, AIDS.

Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: Role of an aggressive approach

D. Samuel, M. L. de la Mata, B. Roche, 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Prognostic factors of survival in HIV/HCV co‐infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort

F. Roudot-thoraval, D. Samuel, P. Nahon, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.

D. Samuel, O. Seror, J. Trinchet, 2015, Radiology.

Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge.

D. Samuel, V. Algalarrondo, T. Antonini, 2015, Gastroenterology.

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

V. de Lédinghen, J. Zucman‐Rossi, M. Ronot, 2021, JHEP reports : innovation in hepatology.

Liver transplantation in HIV-infected patients

D. Samuel, D. Vittecoq, J. Duclos‐Vallée, 2006 .

Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?

V. de Lédinghen, D. Samuel, R. Anty, 2022, Viruses.

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance

V. de Lédinghen, T. Asselah, D. Thabut, 2021, JHEP Reports.

Blockade of CCR5 to protect the liver graft in HIV/HCV co-infected patients.

G. Perlemuter, K. Balabanian, A. Roque-Afonso, 2013, Journal of Hepatology.

Renal Dysfunction in Liver Transplant Patients Treated with Sofosbuvir Based-Regimen for HCV Recurrence: Results from a Large French Prospective Multicentric ANRS CO23 Cupilt

J. Dumortier, F. Durand, A. Tran, 2016 .

HCV and HEV recurrence after liver transplantation: one antiviral therapy for two viruses

D. Samuel, E. Vibert, A. Coilly, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

29 EARLY TRANSPLANTATION IMPROVES SURVIVAL OF NON-RESPONDERS TO CORTICOSTEROIDS IN SEVERE ALCOHOLIC HEPATITIS: A CHALLENGE TO THE 6 MONTH RULE OF ABSTINENCE

F. Pruvot, D. Samuel, J. Dumortier, 2010 .

Infectious complications after liver transplantation in human immunodeficiency virus‐infected recipients

D. Samuel, O. Lambotte, A. Coilly, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Treatment and prognosis of acute severe autoimmune hepatitis

M. Rudler, P. Potier, D. Samuel, 2017 .

Reply to "validation of the SURFASA score to define steroid responsiveness in patients with acute autoimmune hepatitis".

J. Duclos‐Vallée, E. De Martin, 2021, Journal of hepatology.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence after liver transplantation - The CO23 ANRS CUPILT study.

Leroy, D. Samuel, J. Dumortier, 2016 .

P0837 : Efficacy of sofosbuvir and daclatasvir in HIV/HCV co-infected patients with advanced fibrosis

D. Samuel, A. Coilly, D. Vittecoq, 2015 .

P0804 : Efficacy of sofosbuvir-based treatment regimens in HIV/HCV co-infected patients after liver transplantation: The ANRS CO23 CUPILT study

D. Samuel, J. Dumortier, N. Kamar, 2015 .

Immunoglobulin G4-associated autoimmune hepatitis may be found in Western countries.

P. Gual, C. Canivet, S. Patouraux, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

MELD Score Kinetics in Decompensated HIV+/HCV+ Patients

J. Steyaert, R. Anty, L. Meyer, 2015, Medicine.

Adefovir therapy for HBV infection after liver transplantation (LT)

D. Samuel, H. Bismuth, C. Féray, 2002 .

47 EFFICACY AND SAFETY OF PROTEASE INHIBITORS FOR SEVERE HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A FIRST MULTICENTRIC EXPERIENCE

D. Samuel, B. Roche, A. Coilly, 2012 .

Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with a synthetic cohort.

D. Samuel, B. Falissard, J. Duclos‐Vallée, 2011, AIDS.

HCV VIRAL RECURRENCE AND LIVER MITOCHONDRIAL DAMAGE AFTER LIVER TRANSPLANTATION (LT) IN HIV-HCV COINFECTED PATIENTS

D. Samuel, H. Bismuth, C. Jardel, 2004 .

124 HCV viral recurrence and liver mitochondrial damage after liver transplantation (LT) in HIV-HCV coinfected patients

D. Samuel, C. Féray, F. Saliba, 2004 .

Posttransplantation hepatitis E: transfusion-transmitted hepatitis rising from the ashes.

A. Becq, D. Samuel, B. Roche, 2013, Transplantation.

Parvovirus B19 infection: A challenging cause of fulminant hepatitis.

M. Rudler, D. Thabut, D. Samuel, 2020, Clinics and research in hepatology and gastroenterology.

1422 END OF TREATMENT RESPONSE AFTER PROTEASE INHIBITOR (PI)- BASED THERAPY FOR HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC EUROPEAN EXPERIENCE

D. Samuel, J. Dumortier, F. Durand, 2013 .

D. Samuel, E. Vibert, R. Adam, 2011 .

Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with a synthetic cohort.

D. Samuel, B. Falissard, J. Duclos‐Vallée, 2011, AIDS.

Rapid and reliable diagnosis of Wilson disease using X‐ray fluorescence

C. Kewish, D. Samuel, Dominique Bazin, 2016, The journal of pathology. Clinical research.

Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study gets personal.

M. Petit, Karim Si-Tayeb, Jean-Charles Duclos-Vallée, 2012, Journal of hepatology.

Lengthy Follow-up After Liver Transplantation for Nodular Regenerative Hyperplasia in Human Immunodeficiency Virus–Infected Patients: Does the Disease Recur?

D. Samuel, B. Roche, A. Coilly, 2013, Transplantation.

Serologic autoantibodies against tumor associated antigens as potential biomarkers in patients suffering from Hepatocellular carcinoma and Cholangiocarcinoma

Asadullah, E. Ballot, F. Rehman, 2017, 2017 14th International Bhurban Conference on Applied Sciences and Technology (IBCAST).

Immunoproteomic Analysis of Potentially Severe Non‐Graft‐Versus‐Host Disease Hepatitis After Allogenic Bone Marrow Transplantation

J. L. Le Caer, D. Samuel, E. Ballot, 2013, Hepatology.

[Hepatic organoids: What are the challenges?]

A. Messina, B. Cariou, A. Caillaud, 2021, Medecine sciences : M/S.

No hepatic iron overload 12 years after liver transplantation for hereditary hemochromatosis

D. Samuel, C. Guettier, M. Bralet, 2004, Hepatology.

Sofosbuvir‐based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation

Early liver transplantation for severe alcoholic hepatitis.

F. Pruvot, D. Samuel, A. Duhamel, 2011, The New England journal of medicine.

The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable.

D. Samuel, A. Coilly, P. Ichai, 2015, Journal of hepatology.

A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence

D. Samuel, H. Bismuth, E. Ballot, 2003, Gut.

Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort

V. de Lédinghen, D. Samuel, F. Durand, 2019, European Journal of Clinical Pharmacology.

Long term results of liver transplantation for Wilson's disease: experience in France.

D. Samuel, K. Boudjema, J. Dumortier, 2014, Journal of hepatology.

Protein kinase and NO-stimulated ADP-ribosyltransferase activities associated with glyceraldehyde-3-phosphate dehydrogenase isolated from human liver.

H. Mabit, M. Petit, J. Duclos‐Vallée, 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

Are HIV-infected patients candidates for liver transplantation?

R. Weber, D. Samuel, N. Terrault, 2008, Journal of hepatology.

Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.

J. Molina, D. Vittecoq, S. Haim-Boukobza, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis. Five Years of Experience in a Clinical Laboratory.

C. Bouvattier, C. Verstuyft, P. Gaignard, 2021, Clinical chemistry.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study.

V. de Lédinghen, D. Samuel, J. Dumortier, 2016, Journal of hepatology.

219 PROSPECTIVE ASSESSMENT OF LIVER FIBROSIS AFTER LIVER TRANSPLANTATION IN HIV/HCV COINFECTED PATIENTS: A USEFUL TOOL ASSESSING SEVERE FIBROSIS ON THE LIVER GRAFT

D. Samuel, B. Roche, A. Coilly, 2012 .

Severe CPT-11-induced diarrhea in presence of FK-506 following liver transplantation for hepatocellular carcinoma.

F. Goldwasser, F. Lokiec, D. Azoulay, 2001, Anticancer Research.

ATP release after partial hepatectomy regulates liver regeneration in the rat.

D. Samuel, T. Tordjmann, L. Combettes, 2010, Journal of hepatology.

Liver transplant selection criteria and outcomes in critically ill patients with ACLF

C. Féray, F. Saliba, A. Coilly, 2023, JHEP reports : innovation in hepatology.